Pembrolizumab induced acute corneal toxicity after allogeneic stem cell transplantation

Abstract Recently immunotherapy has made considerable progress in cancer treatment. Pembrolizumab is a humanized monoclonal antibody against immune checkpoint programmed death 1 (PD‐1) receptor that is approved for the treatment of unresectable or metastatic melanoma and lung cancer 1,2.
Source: Clinical and Experimental Ophthalmology - Category: Opthalmology Authors: Tags: Letter to the Editor Source Type: research